Antiangiogenic and antitumoral properties of a polysaccharide isolated from the seaweed Sargassum stenophyllum

Folkman J (1971) Tumor angiogenesis: therapeutic implications. N Engl J Med 285:1182–1186 Folkman J, Shing Y (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv Exp Med Biol 313:355–364 Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235:442–447 Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenesis switch. Nat Rev Cancer 3:401–410 Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353–364 Folkman J (1995) Clinical applications of research on angiogenesis. N Engl J Med 333:1757–1763 Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357 Kalluri R (2003) Basement membranes: structure, assembly and role in tumour angiogenesis. Nat Rev Cancer 3:423–433 Fachinger G, Deutsch U, Risau W (1999) Functional interaction of vascular endothelial-protein-tyrosine phosphatase with the angiopoietin receptor Tie-2. Oncogene 18(43):5948–5953 Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J (2000) Vascular specific growth factors and blood vessel formation. Nature 407:242–248 Solimene ACC, Boscardin SB, Ferraz MGC, Chammas R (1999) Angiogenesis in solid tumors. SBOC 1:9–20 Chipperfield H, Kuldip SB, Simon MC, Nurcombe V (2002) Heparan sulfates isolated from adult neural progenitor cells can direct phenotypic maturation. Int J Dev Biol 46:661–670 Nugent MA, Iozzo RV (2000) Fibroblast growth factor-2. Int J Biochem Cell Biol 32:115–120 Folkman J (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1:27–31 Kandel J, Bossy-Wetzel E, Radvanyi F, Klagsbrun M, Folkman J, Hanahan D (1991) Neovascularization is associated with a switch to the export of bFGF in the multistep development of fibrosarcoma. Cell 66:1095–1104 Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257 Koch AE (1998) Angiogenesis. Implications for rheumatoid arthritis. Arthritis Rheum 41(6):951–962 Jones N, Iljin K, Dumont DJ, Alitalo K (2001) Tie receptors: new modulators of angiogenic and lymphangiogenic responses. Nat Rev Mol Cell Biol 2:257–267 Crum R, Szabo S, Folkman J (1985) A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230:1375–1378 Hlatky L, Folkman F (2002) Clinical application antiangiogenic therapy: microvessel density, what it does and doesn’t tell us. J Natl Cancer Inst 94:883–893 Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9(6):653–660 Gagliardi AR, Hadd HE, Collins DC (1992) Inhibition of angiogenesis by suramin. Cancer Res 52:5073–5075 Leali D, Belleri M, Urbinati C, Coltrini D, Oreste P, Zoppetti G, Ribatti D, Rusnati M, Presta M (2001) Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem 276(41):37900–37908 Cristofanilli M, Charnsangavej C, Ortobagyi GN (2002) Angiogenesis modulation in cancer research: novel clinical approaches. Nat Rev Drug Discov 1:415–426 Koyanagi S, Tanigawa N, Nakagawa H, Soeda S, Shimeno H (2003) Oversulfation of fucoidan enhances its anti-angiogenic and antitumor activities. Biochem Pharmacol 65:173–179 Tan W, Lin L, Li M, Zhang YX, Tong Y, Xiao D, Ding J (2003) Quercetin, a dietary-derived flavonoid, possesses antiangiogenic potential. Eur J Pharmacol 459(2):255–262 Chen HH, Zhou HJ, Wang WQ, Wu GD (2004) Antimalarial dihydroartemisin also inhibits angiogenesis. Cancer Chemother Pharmacol 53:423–432 Albano RM, Pavao MS, Mourao PA, Mulloy B (1990) Structural studies of a sulfated L-galactan from Styela plicata (Tunicate): analysis of the Smith-degraded polysaccharide. Carbohydr Res 208:163–174 Berlinck RG, Ogawa CA, Almeida AM, Sanchez MA, Malpezzi EL, Costa LV, Hajdu E, de Freitas JC (1996) Chemical and pharmacological characterization of halitoxin from Amphimedon viridis (Porifera) from the southeastern Brazilian coast. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol 115(2):155–163 Mian AJ, Percival E (1973) Carbohydrates of the brown seaweeds Himanthalia lorea and Bifurcaria bifurcata. Structural studies of the “fucans”. Carbohydr Res 26:147–156 Abdel-Fattah A, Hussein MM-D, Salem HM (1974) Studies of the purification and some properties of sargassan, a sulphated heteropolysaccharide from Sargassum linifolium. Carbohydr Res 33:9–17 Nishino T, Yokoyama G, Dobashi K, Fujihara M, Nagumo T (1989) Isolation, purification, and characterization of fucose-containing sulfated polysaccharides from the brown seaweed Ecklonia kurome and their blood-anticoagulant activities. Carbohydr Res 186:119–129 Nishino T, Nagumo T (1992) Anticoagulant and antithrombin activities of oversulfated fucans. Carbohydr Res 229:355–362 Mayer AMS, Paul VJ, Fenical W, Norris JN, Carvalho MS, Jacobs RS (1993) Phospholipase A2 inhibitors from marine algae. Hydrobiologia 260:521–529 König GM, Wright AD (1995) Marine natural products research. Current directions and future potential. Planta Med 62:193–211 Noda H, Amano H, Arashima K, Hashimoto S, Nisizawa K (1989) Studies on the antitumor activity of marine algae. Nippon Suissan Gakkaishi 55(7):1259–1264 Duarte MER, Cardoso MA, Noseda M, Cerezo AS (2001) Structural studies on fucoidans from the brown seaweed Sargassum stenophyllum. Carbohydr Res 333:281–293 Grumet M, Flaceus A, Margolis RRU (1993) Functional characterization of chondroitin sulphate proteoglycans of brain: interaction with neuron and neural cell adhesion molecules. J Cell Biol 120(3):815–824 Katz BZ, Yamada KM (1997) Integrins in morphogenesis and signaling. Biochimie 79:467–476 Selvendran RR, Stevens BJH, O’Neill MA (1985) Developments in the isolation and analysis of cell walls from edible plants. In: Brett CT, Hillman JR (eds) Biochemistry of the plant cell wall, Cambridge University Press, London, pp 39–78 Maraschin M, Carobrez SG, Persike D, Peixoto Ml, Ferreira AG, Ferracin R, Verpoorter R, Fontana JD (2000) Cell wall polysaccharides from Mandevilla velutina (Apocynaceae) cultured cells: extraction and chemical structure. Carbohydr Polym 41:55–60 Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254 Blumenkrantz N, Asboe-Hansen G (1973) New method for quantitative determination of uronic acids. Anal Biochem 54:484–489 Gagliardi AR, Collins DC (1993) Inhibition of angiogenesis by antiestrogens. Cancer Res 53:533–535 Drabkin DL, Austin JH (1932) Spectrophotometric constants for common haemoglobin derivatives in human, dog, and rabbit blood. J Biol Chem 98:719–722 Lee YS, Yang HO, Shin KH, Choi HS, Jung SH, Hoon S, Kim YM, Oh DK, Linhardt RJ, Kim YS (2003) Suppression of tumor growth by a new glycosaminoglycan isolated from the African giant snail Achatina fulica. Eur J Pharmacol 465:191–198 Ingber D, Fugita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J (1990) Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555–557 Burke RR (1973) A factor from a transformed cell line that affects cell migration. Proc Natl Acad Sci U S A 70:368–372 Igura K, Ohta T, Kuroda Y, Kaji K (2001) Resveratrol and quercetin inhibit angiogenesis in vitro. Cancer Lett 171:11–16 Carmichael J, Degraff WG, Gazdar AF, Minn JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47:936–942 Carlucci MJ, Pujol CA, Ciancia C, Noseda MD, Matulewicz MC, Damonte EB, Cerezo AS (1997) Antiherpetic and anticoagulant properties of carrageenans from the red seaweed Gigartina skottsbergii and their cyclized derivatives: correlation between structure and biological activity. Int J Biol Macromol 20:97–105 Orr SF (1954) Infra-red spectroscopic studies of some polysaccharides. Biochem Biophys Acta 14:173–181 Nguyen M, Shing Y, Folkman J (1994) Quantitation of angiogenesis and antiangiogenesis in the chick embryo chorioallantoic membrane. Microvasc Res 47:31–40 Jackson CJ, Giles I, Knop A, Nethery A, Schrieber L (1994) Sulfated polysaccharides are required for collagen-induced vascular tube formation. Exp Cell Res 215:294–302 Gallagher JT (1994) Heparan sulphates as membrane receptors for the fibroblast growth factor. Eur J Clin Chem Clin Biochem 32:239–247 Dowd CJ, Cooney CL, Nugent MA (1999) Heparan sulfate mediates bFGF transport through basement membrane by diffusion with rapid reversible binding. J Biol Chem 274:5236–5244 Miao H, Ornitz DM, Aingorn E, Ben-Sasson SA, Vlodavsky I (1997) Modulation of fibroblast growth factor-2 receptor binding, dimerization, signaling, and angiogenic activity by a synthetic heparin-mimicking polyanionic compound. J Clin Invest 99:1565–1575 Mundhenke C, Meyer K, Drew S, Friedl A (2002) Heparan sulfate proteoglycans as regulators of fibroblast growth factor-2 receptor binding in breast carcinomas. Am J Pathol 160:185–194 Matou S, Helly D, Chabut D, Bros A, Fischer A-M (2002) Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. Thromb Res 106:213–221 Soeda S, Kosako T, Iwata K, Shimeno H (2000) Oversulfated fucoidan inhibits the basic fibroblast growth factor-induced tube formation by human umbilical vein endothelial cells: its possible mechanism of action. Biochim Biophys Acta 1497:127–134 Coffey RJ Jr, Leof EB, Shipley GD, Moses HL (1987) Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells. J Cell Physiol 132:143–148 Yayon A, Klagsbrun M (1990) Autocrine transformation by chimeric signal peptide–basic fibroblast growth factor: reversal by suramin. Proc Natl Acad Sci U S A 87:5346–5350 Pesenti E, Sol F, Mongelli N, Grandi M, Spreafico F (1992) Suramin prevents neovascularization and tumor growth through blocking of basic fibroblast growth factor activity. Br J Cancer 66:367–374 Fairbrother WJ, Champe MA, Christinger HW, Keyt BA, Starovasnik MA (1998) Solution structure of the heparin-binding domain vascular endothelial growth factor. Structure 6:637–648 Princivalle M, de Agostini A (2002) Developmental roles of heparan sulfate proteoglycans a comparative review in Drosophila, mouse and human. Int J Dev Biol 46:267–278 Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP Jr (2001) Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science 293:1663–1666 Burg MA, Halfter W, Cole GJ (1995) Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule. J Neurosci Res 41:49–64 Tobelem G (1990) Endothelial cell growth: biology and pharmacology in relation to angiogenesis. Blood Coagul Fibrinolysis 1:703–705 Takaku T, Kimura Y, Okuda H (2001) Isolation of an antitumor compound from Agaricus blazei Murill and its mechanism of action. J Nutr 131:1409–1413 Nguyen NM, Leer JE, Pienta KJ (1993) Pentosan inhibits angiogenesis in vitro and suppresses prostate tumor growth in vivo. Anticancer Res 13(6A):2143–2147 Zhang N, Deuel TF (1999) Pleiotrophin and midkine, a family of mitogenic and angiogenic heparin-binding growth and differentiation factors. Curr Opin Hematol 6:44–50 Zeng C, Toole BP, Kinney SD, Kuo JW, Stamenkovic I (1998) Inhibition of tumor growth in vivo by hyaluronan oligomers. Int J Cancer 77(3):396–401 Soeda S, Shibata Y, Shimeno H (1997) Inhibitory effect of oversulfated fucoidan on tube formation by human vascular endothelial cells. Biol Pharm Bull 20(11):1131–1135 Soeda S, Sakaguchi S, Shimeno H, Nagamatsu A (1992) Fibrinolytic and coagulant activities of highly sulfated fucoidan. Biochem Pharmacol 43(8):1853–1858 Stein CA, La Rocca RV, Thomas R, McAtee N, Myers CE (1989) Suramin: an anticancer drug with a unique mechanism of action. J Clin Oncol 7:499–508 Gill JS, Windebank AJ (1998) Suramin induced ceramide accumulation leads to apoptotic cell death in dorsal root ganglion neurons. Cell Death Differ 5(10):876–883 Myers C, Cooper M, Stein C, La Rocca R, McClellan MW, Weiss G, Choyke P, Dawson N, Steinberg S, Uhrich MM, Cassidy J, Kohler DR, Trepel J, Linehan MW (1992) Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer. J Clin Oncol 10:881–889 Mauray S, Sternberg C, Theveniaux J, Millet J, Sinquin C, Tapon-Bretaudiere J, Fischer AM (1995) Venous antithrombotic and anticoagulant activities of a fucoidan fraction. Thromb Haemost 74:1280–1285